Bruno Daniele Leoni has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High-Sensitivity Cardiac Troponin I in Apparently Healthy Blood Donors: Cross-Sectional Distribution and Discordance with Conventional Cardiovascular Risk Assessment Methods

    by Stefano Pignalosa, Valeria Carnazzo, Sara Tartaglione, Massimo Pieri, Raffaella Marzano, Bruno Daniele Leoni, Francesco Versaci, Mariapaola Marino, Umberto Basile, Francesco Equitani

    Background: Interpreting low-grade of high-sensitivity cardiac troponin I (hs-TnI) concentrations reflecting myocardial injury in asymptomatic populations remains clinically uncertain. This study characterized predefined sex-specific hs-TnI categories in apparently healthy blood donors and compared them with conventional cardiovascular assessment methods. Methods: We performed a cross-sectional analysis of 292 blood donors (77 women, 26.4%; 215 men, 73.6%; age range, 40–65 years). Hs-TnI was measured using the Abbott ARCHITECT STAT High Sensitive Troponin-I assay and categorized according to predefined sex-specific thresholds. Categories were compared with clinical variables, cholesterol/HDL-ratio categories, Framingham Risk Score categories, and SCORE2 in eligible participants (n = 287). Additional analyses included non-parametric comparisons, Spearman correlations, agreement statistics, and multivariable models. A sensitivity analysis used sex-specific empirical hs-TnI tertiles, and effect sizes with bootstrap 95% confidence intervals were reported for key comparisons. Results: Hs-TnI categories were low in 253 subjects (86.6%), intermediate in 17 (5.8%), and elevated in 22 (7.5%). Hs-TnI was markedly skewed, especially in the elevated category (median, 21.5 ng/L; IQR, 15.25–36.0; range, 11–199). Agreement with conventional categories was low, with weighted kappa values of 0.035 versus Framingham, −0.008 versus cholesterol/HDL-ratio categories, and 0.076 versus SCORE2. Conventional cardiovascular variables showed limited independent association with intermediate/elevated hs-TnI categories. Tertile-based sensitivity analyses yielded weighted kappa values of 0.045 versus Framingham, 0.033 versus cholesterol/HDL-ratio categories, and 0.037 versus SCORE2. Conclusions: In selected blood donors, predefined hs-TnI categories showed limited concordance with conventional cardiovascular scores, exploratory-wise suggesting a distinct phenotype of low-grade myocardial injury.

  • Open Access

    Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg

    by Silvia Meschi, Klizia Mizzoni, Bruno Daniele Leoni, Claudio Galli, Anna Rosa Garbuglia, Stefano Belladonna, Enrico Girardi, Fabrizio Maggi, the HBSAGN Study Group

    We investigated the frequency and serological correlates of occult hepatitis B virus infection (OBI) and the potential impact of a highly sensitive assay for HBsAg in subjects infected by human immunodeficiency virus (HIV) or hepatitis C virus (HCV), who are also at risk for hepatitis B virus (HBV) infection, often in an occult form. Samples from 499 patients with HIV, all HBsAg negative and anti-HBc positive, and 137 patients with HCV were tested for HBV-DNA, anti-HBc, anti-HBs, and HBsAg by a conventional and highly sensitive assay. HBV biomarkers were detected in 71.5% of HCV-RNA-positive, with a higher prevalence of cases positive only for anti-HBc in patients with HCV than in those with HIV. HBV-DNA was detectable in 0.6% of HIV-positive and 7.3% of HCV-RNA-positive patients. Among patients with HCV, four were positive for HBsAg and negative for HBV-DNA, bringing the rate of HBV-active infection in this group to 10.2%. Active HBV infection was not related to gender or specific patterns of HBV biomarkers but was higher in HCV patients coinfected by HIV compared to those infected only by HCV. Monitoring patients at high risk for HBV infection and reactivation may require testing for both HBV-DNA and HBsAg.


  • Open Access

    Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay

    by Marta Fogolari, Bruno Daniele Leoni, Marina De Cesaris, Rita Italiano, Flavio Davini, Ginevra Azzurra Miccoli, Daniele Donati, Luigi Clerico, Andrea Stanziale, Giovanni Savini, et al.

    Background: Monitoring antibody response following SARS-CoV-2 vaccination is strategic, and neutralizing antibodies represent the gold standard. The neutralizing response to Beta and Omicron VOCs was evaluated versus the gold standard by a new commercial automated assay. Methods: Serum samples from 100 healthcare workers from the Fondazione Policlinico Universitario Campus Biomedico and the Pescara Hospital were collected. IgG levels were determined by chemiluminescent immunoassay (Abbott Laboratories, Wiesbaden, Germany) and serum neutralization assay as the gold standard. Moreover, a new commercial immunoassay, the PETIA test Nab (SGM, Rome, Italy), was used for neutralization evaluation. Statistical analysis was performed with R software, version 3.6.0. Results: Anti-SARS-CoV-2 IgG titers decayed during the first ninety days after the vaccine second dose. The following booster dose significantly (p < 0.001) increased IgG levels. A correlation between IgG expression and neutralizing activity modulation was found with a significant increase after the second and the third booster dose (p < 0.05. Compared to the Beta variant of the virus, the Omicron VOC was associated with a significantly larger quantity of IgG antibodies needed to achieve the same degree of neutralization. The best Nab test cutoff for high neutralization titer (≥1:80) was set for both Beta and Omicron variants. Conclusion: This study correlates vaccine-induced IgG expression and neutralizing activity using a new PETIA assay, suggesting its usefulness for SARS-CoV2 infection management.


  • Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine

    by Silvia Meschi, Giulia Matusali, Francesca Colavita, Daniele Lapa, Licia Bordi, Vincenzo Puro, Bruno D. Leoni, Claudio Galli, Maria Rosaria Capobianchi, Concetta Castilletti, et al.

    Objectives: Simple and standardized methods to establish correlates to vaccine-elicited SARS-CoV-2 protection are needed. Methods: An observational study on antibody response to a mRNA vaccine (Comirnaty) was performed on health care workers (V, n=120). Recovered COVID-19 patients (N, n=94) were used for comparison. Antibody response was evaluated by a quantitative anti-receptor binding domain IgG (anti-RBD) commercial assay and by virus microneutralization test (MNT), in order to establish a threshold of anti-RBD binding antibody units (BAU) able to predict a robust (≥1:80) MNT titer. Results: Significant correlation between BAU and MNT titers was found in both V and N, being stronger in V (rs=0.91 and 0.57 respectively, p<0.001); a higher incremental trend starting from MNT titer 1:80 was observed in the V group. The 99% probability of high MNT titer (≥1:80) was reached at 1,814 and 3,564 BAU/mL, and the area under the receiver operating characteristic (ROC) curve was 0.99 (CI: 0.99–1.00) and 0.78 (CI: 0.67–0.86) in V and N, respectively. Conclusions: A threshold of 2,000 BAU/mL is highly predictive of strong MNT response in vaccinated individuals and may represent a good surrogate marker of protective response. It remains to be established whether the present results can be extended to BAU titers obtained with other assays.


  • Serum iPTH range in a reference population: From an integrated approach to vitamin D prevalence impact evaluation

    by Marilena Minieri, Bruno Daniele Leoni, Lorenza Bellincampi, Daniela Bajo, Alessia Agnoli, Anna Maria De Angelis, Massimo Pieri, Francesco Equitani, Vincenzo Rossi, Filippa Valente, et al.


  • Good Caco-2 cell culture practices

    by Manuela Natoli, Bruno D. Leoni, Igea D’aGnano, Flavia Zucco, Armando Felsani


  • Differentiation of Caco-2 cells requires both transcriptional and post-translational down-regulation of Myc

    by Bruno Daniele Leoni, Manuela Natoli, Marta Nardella, Barbara Bucci, Flavia Zucco, Igea D'AGnano, Armando Felsani


  • Cell growing density affects the structural and functional properties of Caco‐2 differentiated monolayer

    by Manuela Natoli, Bruno D. Leoni, Igea D'AGnano, Mara D'ONofrio, Rossella Brandi, Ivan Arisi, Flavia Zucco, Armando Felsani

    The human intestinal Caco‐2 cell line has been extensively used as a model of the intestinal barrier. However, it is widely reported in literature that culture‐related conditions, as well as the different Caco‐2 cell lines utilized in different laboratories, often lead to problems of reproducibility making difficult to compare results. We developed a new cell‐maintenance protocol in which Caco‐2 cells were subcultured at 50% of confluence instead of 80% of confluence, as usually suggested. Using this new protocol, Caco‐2 cells retained a higher proliferation potential resulting in a cell population, which, on reaching confluence, was able to differentiate almost synchronously, forming a more homogeneous and polarized cell monolayer, as compared to that obtained using a high cell growing density. This comparison has been done by analyzing the gene expression and the structural characteristics of the 21‐days differentiated monolayers by microarrays hybridization and by confocal microscopy. We then investigated if these differences could also modify the effects of toxicants on 21‐days‐differentiated cells. We analyzed the 2 h‐acute toxicity of CuCl2 in terms of actin depolymerization and metallothionein 2A (MT2A) and heat shock protein 70 (HSPA1A) genes induction. Copper treatment resulted in different levels of actin depolymerization and gene expression induction in relationship with culture protocol, the low‐density growing cells showing a more homogeneous and stronger response. Our results suggest that cell growing density could influence a number of morphological and physiological properties of differentiated Caco‐2 cells and these effects must be taken in account when these cells are used as intestinal model. J. Cell. Physiol. 226: 1531–1543, 2011.